Brown Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.3M | Sell |
110,470
-5,588
| -5% | -$240K | 0.01% | 540 |
|
|
2026
Q1 | $4.27M | Buy |
116,058
+2,757
| +2% | +$131K | 0.01% | 557 |
|
|
2025
Q4 | $5.76M | Buy |
113,301
+6,261
| +6% | +$320K | 0.01% | 520 |
|
|
2025
Q3 | $5.94M | Sell |
107,040
-7,117
| -6% | -$417K | 0.01% | 505 |
|
|
2025
Q2 | $7.88M | Sell |
114,157
-288
| -0.3% | -$19.6K | 0.01% | 445 |
|
|
2025
Q1 | $7.95M | Sell |
114,445
-1,302
| -1% | -$108K | 0.01% | 435 |
|
|
2024
Q4 | $9.96M | Buy |
115,747
+3,793
| +3% | +$410K | 0.01% | 430 |
|
|
2024
Q3 | $13.3M | Sell |
111,954
-3,037
| -3% | -$405K | 0.02% | 377 |
|
|
2024
Q2 | $16.4M | Buy |
114,991
+5,433
| +5% | +$720K | 0.02% | 344 |
|
|
2024
Q1 | $14.1M | Buy |
109,558
+2,618
| +2% | +$312K | 0.02% | 368 |
|
|
2023
Q4 | $11.1M | Sell |
106,940
-920
| -0.9% | -$91K | 0.02% | 393 |
|
|
2023
Q3 | $9.81M | Sell |
107,860
-2,200
| -2% | -$194K | 0.02% | 388 |
|
|
2023
Q2 | $8.91M | Buy |
110,060
+3,660
| +3% | +$299K | 0.01% | 409 |
|
|
2023
Q1 | $8.47M | Buy |
106,400
+4,196
| +4% | +$298K | 0.01% | 412 |
|
|
2022
Q4 | $6.92M | Buy |
102,204
+194
| +0.2% | +$11.4K | 0.01% | 426 |
|
|
2022
Q3 | $5.08M | Buy |
102,010
+1,792
| +2% | +$96K | 0.01% | 449 |
|
|
2022
Q2 | $5.58M | Sell |
100,218
-500
| -0.5% | -$27.7K | 0.01% | 445 |
|
|
2022
Q1 | $5.59M | Buy |
100,718
+90,860
| +922% | +$4.66M | 0.01% | 460 |
|
|
2021
Q4 | $552K | Sell |
9,858
-640
| -6% | -$34.7K | ﹤0.01% | 847 |
|
|
2021
Q3 | $504K | Sell |
10,498
-1,828
| -15% | -$88.4K | ﹤0.01% | 825 |
|
|
2021
Q2 | $515K | Sell |
12,326
-632
| -5% | -$24.5K | ﹤0.01% | 838 |
|
|
2021
Q1 | $437K | Buy |
12,958
+1,452
| +13% | +$51.7K | ﹤0.01% | 869 |
|
|
2020
Q4 | $401K | Buy |
11,506
+1,326
| +13% | +$45.8K | ﹤0.01% | 823 |
|
|
2020
Q3 | $353K | Sell |
10,180
-874
| -8% | -$29.1K | ﹤0.01% | 796 |
|
|
2020
Q2 | $362K | Sell |
11,054
-74
| -0.7% | -$2.36K | ﹤0.01% | 787 |
|
|
2020
Q1 | $335K | Sell |
11,128
-80
| -0.7% | -$2.38K | ﹤0.01% | 764 |
|
|
2019
Q4 | $324K | Buy |
+11,208
| New | +$310K | ﹤0.01% | 862 |
|
|
2019
Q3 | – | Sell |
-12,152
| Closed | -$310K | – | 1027 |
|
|
2019
Q2 | $310K | Sell |
12,152
-14,402
| -54% | -$356K | ﹤0.01% | 861 |
|
|
2019
Q1 | $694K | Sell |
26,554
-1,456
| -5% | -$35.8K | ﹤0.01% | 899 |
|
|
2018
Q4 | $645K | Sell |
28,010
-452
| -2% | -$10K | ﹤0.01% | 867 |
|
|
2018
Q3 | $670K | Sell |
28,462
-1,182
| -4% | -$28.8K | ﹤0.01% | 919 |
|
|
2018
Q2 | $684K | Sell |
29,644
-25,342
| -46% | -$602K | ﹤0.01% | 891 |
|
|
2018
Q1 | $1.35M | Buy |
54,986
+40
| +0.1% | +$1.05K | ﹤0.01% | 591 |
|
|
2017
Q4 | $1.48M | Sell |
54,946
-2,226
| -4% | -$56.6K | ﹤0.01% | 589 |
|
|
2017
Q3 | $1.38M | Sell |
57,172
-5,126
| -8% | -$116K | ﹤0.01% | 592 |
|
|
2017
Q2 | $1.34M | Sell |
62,298
-2,086
| -3% | -$42.1K | ﹤0.01% | 616 |
|
|
2017
Q1 | $1.1M | Buy |
64,384
+10,778
| +20% | +$188K | ﹤0.01% | 620 |
|
|
2016
Q4 | $962K | Sell |
53,606
-8,718
| -14% | -$158K | ﹤0.01% | 641 |
|
|
2016
Q3 | $1.3M | Sell |
62,324
-5,098
| -8% | -$126K | ﹤0.01% | 567 |
|
|
2016
Q2 | $1.81M | Sell |
67,422
-187,448
| -74% | -$5.14M | 0.01% | 513 |
|
|
2016
Q1 | $6.91M | Sell |
254,870
-117,978
| -32% | -$3.16M | 0.02% | 321 |
|
|
2015
Q4 | $10.8M | Buy |
372,848
+37,410
| +11% | +$1.04M | 0.04% | 271 |
|
|
2015
Q3 | $9.1M | Buy |
335,438
+44,162
| +15% | +$1.25M | 0.03% | 284 |
|
|
2015
Q2 | $7.98M | Sell |
291,276
-4,514
| -2% | -$127K | 0.03% | 295 |
|
|
2015
Q1 | $7.9M | Sell |
295,790
-74,064
| -20% | -$1.71M | 0.03% | 300 |
|
|
2014
Q4 | $7.83M | Buy |
369,854
+36,578
| +11% | +$817K | 0.02% | 299 |
|
|
2014
Q3 | $7.93M | Buy |
333,276
+302,978
| +1,000% | +$6.97M | 0.03% | 299 |
|
|
2014
Q2 | $699K | Buy |
30,298
+188
| +0.6% | +$4.15K | ﹤0.01% | 615 |
|
|
2014
Q1 | $687K | Sell |
30,110
-1,990
| -6% | -$42.4K | ﹤0.01% | 605 |
|
|
2013
Q4 | $593K | Buy |
+32,100
| New | +$559K | ﹤0.01% | 612 |
|
Other funds holding NVO
F
Brown Advisory's NVO Position: Q2 2026 in Review
Brown Advisory reduced its Novo Nordisk (NVO) stake by 4.8% in Q2 2026, selling an estimated $240K and leaving 110,470 shares worth $5.3M. The position accounts for 0.01% of the portfolio, ranked #540.
Brown Advisory first reported a position in NVO in Q4 2013 and has held it in 50 quarters since. The position peaked at $16.4M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Brown Advisory held 110,470 shares of Novo Nordisk worth $5.3M as of Q2 2026.
- Brown Advisory sold 5,588 Novo Nordisk shares in Q2 2026, an estimated $240K.
- Novo Nordisk made up 0.01% of Brown Advisory's portfolio in Q2 2026, its #540 holding.
- Brown Advisory first reported a position in Novo Nordisk in Q4 2013 and has held it in 50 quarters since.
- Brown Advisory's Novo Nordisk position peaked at $16.4M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.